OtherSpecial Contribution
Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease
Hossein Jadvar, Patrick Colletti, Roberto Delgado-Bolton, Giuseppe Esposito, Bernd Krause, Andrei Iagaru, Helen Nadel, David Quinn, Eric Rohren, Rathan Subramaniam, Katherine Zukotynski, Julie Kauffman, Sukhjeet Ahuja and Landis K. Griffeth
Journal of Nuclear Medicine October 2017, jnumed.117.197988; DOI: https://doi.org/10.2967/jnumed.117.197988
Hossein Jadvar
1 University of Southern California, United States;
Patrick Colletti
2 University of Southern California Keck School of Medicine, United States;
Roberto Delgado-Bolton
3 Hospital San Pedro - CIBIR, Spain;
Giuseppe Esposito
4 SNMMI, United States;
Bernd Krause
5 University of Rostock, Germany;
Andrei Iagaru
6 Stanford University Medical Center, United States;
Helen Nadel
7 British Columbia Children''s Hospital, Canada;
David Quinn
8 USC Norris, United States;
Eric Rohren
9 The University of Texas MD Anderson Cancer Center, United States;
Rathan Subramaniam
10 UT Southwestern Medical Center, United States;
Katherine Zukotynski
11 McMaster University, Canada;
Julie Kauffman
4 SNMMI, United States;
Sukhjeet Ahuja
4 SNMMI, United States;
Landis K. Griffeth
12 Baylor University Medical Center, United States
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease
Hossein Jadvar, Patrick Colletti, Roberto Delgado-Bolton, Giuseppe Esposito, Bernd Krause, Andrei Iagaru, Helen Nadel, David Quinn, Eric Rohren, Rathan Subramaniam, Katherine Zukotynski, Julie Kauffman, Sukhjeet Ahuja, Landis K. Griffeth
Journal of Nuclear Medicine Oct 2017, jnumed.117.197988; DOI: 10.2967/jnumed.117.197988
Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease
Hossein Jadvar, Patrick Colletti, Roberto Delgado-Bolton, Giuseppe Esposito, Bernd Krause, Andrei Iagaru, Helen Nadel, David Quinn, Eric Rohren, Rathan Subramaniam, Katherine Zukotynski, Julie Kauffman, Sukhjeet Ahuja, Landis K. Griffeth
Journal of Nuclear Medicine Oct 2017, jnumed.117.197988; DOI: 10.2967/jnumed.117.197988
Jump to section
Related Articles
Cited By...
- Reducing Radiation Exposure from PET Patients
- Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy
- 18F-Sodium Fluoride PET: History, Technical Feasibility, Mechanism of Action, Normal Biodistribution, and Diagnostic Performance in Bone Metastasis Detection Compared with Other Imaging Modalities
- Development of Simple Methods to Reduce the Exposure of the Public to Radiation from Patients Who Have Undergone 18F-FDG PET/CT
- PET/CT Versus Standard Imaging for Prediction of Survival in Patients with Recurrent Head and Neck Squamous Cell Carcinoma
- Reply: Staging, Restaging, and Treatment Response Assessment in Lymphomas: What We Should Know
- Staging, Restaging, and Treatment Response Assessment in Lymphomas: What We Should Know